Back to top

Analyst Blog

Ventas, Inc. (VTR - Analyst Report) recently announced that it is on the look out for prospective tenants for 64 healthcare assets, which are currently leased to Kindred Healthcare, Inc. under four Master Leases. Kindred currently pays an annual cash rent of $77 million for the assets. The lease term of these assets is scheduled to expire April 30, 2013.

Kindred indicated that it intends to renew its leases on 25 health care assets, totaling $46 million of the current annual rent. However, Kindred has already renewed lease term for 8 of the 25 assets. The renewal lease term for these 25 assets commences on May 1, 2013 and is set to expire on April 30, 2018.

Ventas has one of the largest and most diversified portfolios in the healthcare sector with exposure to all types of facilities. The product diversity of the company allows it to capitalize on opportunities in different markets based on individual market dynamics. These assets will be attractive to a wide variety of quality healthcare providers, and is expected to improve its portfolio diversification and broaden its tenant base.

Ventas reported fourth 2011 funds from operations (FFO) of $359.1 million or $1.24 per share, compared to $108.3 million or $0.68 in the year-earlier quarter. Fund from operations, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and other non-cash expenses to net income. With superior quarterly results, Ventas expects its FFO guidance for full year 2012 to be in the range of $3.63 – $3.69 per share.

Ventas is a leading healthcare real estate investment trust. Its diverse portfolio of more than 1,300 assets in 47 states (including the District of Columbia) and two Canadian provinces consists of seniors housing communities, skilled nursing facilities, hospitals, medical office buildings and other properties.

Ventas currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Outperform recommendation on the stock. One of its competitors, HCP Inc. (HCP - Analyst Report) also holds a Zacks #3 Rank.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.80 +7.04%
BANCO DO BR… BDORY 14.74 +5.66%
AIR INDUSTR… AIRI 9.99 +4.15%
EQT MIDSTRE… EQM 98.14 +3.38%
WEATHERFORD… WFT 23.64 +3.10%